Walleye Capital’s Amylyx Pharmaceuticals AMLX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-250,888
| Closed | -$888K | – | 1862 |
|
|
2025
Q1 | $888K | Sell |
250,888
-267,896
| -52% | -$948K | ﹤0.01% | 883 |
|
|
2024
Q4 | $1.96M | Sell |
518,784
-151,810
| -23% | -$574K | ﹤0.01% | 703 |
|
|
2024
Q3 | $2.17M | Buy |
670,594
+608,874
| +987% | +$1.97M | ﹤0.01% | 729 |
|
|
2024
Q2 | $117K | Sell |
61,720
-300,150
| -83% | -$570K | ﹤0.01% | 2015 |
|
|
2024
Q1 | $1.03M | Sell |
361,870
-220,858
| -38% | -$627K | ﹤0.01% | 1032 |
|
|
2023
Q4 | $8.58M | Buy |
582,728
+481,769
| +477% | +$7.09M | 0.02% | 231 |
|
|
2023
Q3 | $1.85M | Buy |
100,959
+48,581
| +93% | +$890K | ﹤0.01% | 682 |
|
|
2023
Q2 | $1.13M | Buy |
+52,378
| New | +$1.13M | ﹤0.01% | 706 |
|
|
2023
Q1 | – | Sell |
-17,492
| Closed | -$646K | – | 2099 |
|
|
2022
Q4 | $646K | Sell |
17,492
-44,390
| -72% | -$1.64M | 0.01% | 900 |
|
|
2022
Q3 | $1.74M | Buy |
+61,882
| New | +$1.74M | 0.03% | 506 |
|
|
2022
Q2 | – | Sell |
-28,187
| Closed | -$362K | – | 2269 |
|
|
2022
Q1 | $362K | Buy |
+28,187
| New | +$362K | 0.01% | 1156 |
|